Abstract
Previous studies assessing the association between serum uric acid levels and neurological outcome after acute ischemic stroke reported conflicting results. A systematic review and meta-analysis were conducted to assess the impact of serum uric acid levels on outcome after acute ischemic stroke. Pubmed, Embase, Web of Science, and Google scholar were searched through September 26, 2014 to identify eligible published or unpublished studies on the association between serum uric acid levels and outcome after acute ischemic stroke. Hazard ratio (HR) for poor outcome or mean differences of serum uric acid levels with 95 % confidence intervals (95 % CIs) were pooled using meta-analysis. The primary outcome was occurrence of poor outcomes, while the secondary outcome was the mean differences of serum uric acid levels in patients with good or poor outcomes. Ten eligible studies with a total of 8131 acute ischemic stroke patients were included into the meta-analysis. Compared with low serum uric acid level, high serum uric acid level was associated better outcome after acute ischemic stroke (HR = 0.77, 95 % CI 0.68–0.88, P = 0.0001). Sensitivity analysis further identified the prognostic role of serum uric acid levels on outcome after acute ischemic stroke. Patients with good outcomes had a higher serum uric acid level compared with those with poor outcome (mean difference = 30.61 μmol/L, 95 % CI 20.13–41.08, P < 0.00001). There was no obvious risk of publication bias in the meta-analysis. This meta-analysis supports that serum uric acid level has a protective effect on neurological outcome after acute ischemic stroke. High uric acid level at the onset is a biomarker of better prognosis in patients with acute ischemic stroke.
Similar content being viewed by others
References
Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O'Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C (2014) Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 383(9913):245–254
Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, Lansberg M, Lindley RI, Murray G, Olivot JM, Parsons M, Tilley B, Toni D, Toyoda K, Wahlgren N, Wardlaw J, Whiteley W, Del Zoppo GJ, Baigent C, Sandercock P, Hacke W (2014) Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet
Grefkes C, Fink GR (2014) Connectivity-based approaches in stroke and recovery of function. Lancet Neurol 13(2):206–216
Koton S, Schneider AL, Rosamond WD, Shahar E, Sang Y, Gottesman RF, Coresh J (2014) Stroke incidence and mortality trends in US communities, 1987 to 2011. JAMA 312(3):259–268
Hackett ML, Kohler S, O'Brien JT, Mead GE (2014) Neuropsychiatric outcomes of stroke. Lancet Neurol 13(5):525–534
Maaijwee NA, Rutten-Jacobs LC, Schaapsmeerders P, van Dijk EJ, de Leeuw FE (2014) Ischaemic stroke in young adults: risk factors and long-term consequences. Nat Rev Neurol 10(6):315–325
So A, Thorens B (2010) Uric acid transport and disease. J Clin Invest 120(6):1791–1799
Cherubini A, Polidori MC, Bregnocchi M, Pezzuto S, Cecchetti R, Ingegni T, di Iorio A, Senin U, Mecocci P (2000) Antioxidant profile and early outcome in stroke patients. Stroke 31(10):2295–2300
Romanos E, Planas AM, Amaro S, Chamorro A (2007) Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab 27(1):14–20
Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P (2014) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute Web site
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748
Chamorro A, Obach V, Cervera A, Revilla M, Deulofeu R, Aponte JH (2002) Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke 33(4):1048–1052
Wong KY, MacWalter RS, Fraser HW, Crombie I, Ogston SA, Struthers AD (2002) Urate predicts subsequent cardiac death in stroke survivors. Eur Heart J 23(10):788–793
Weir CJ, Muir SW, Walters MR, Lees KR (2003) Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 34(8):1951–1956
Newman EJ, Rahman FS, Lees KR, Weir CJ, Walters MR (2006) Elevated serum urate concentration independently predicts poor outcome following stroke in patients with diabetes. Diabetes Metab Res Rev 22(1):79–82
Karagiannis A, Mikhailidis DP, Tziomalos K, Sileli M, Savvatianos S, Kakafika A, Gossios T, Krikis N, Moschou I, Xochellis M, Athyros VG (2007) Serum uric acid as an independent predictor of early death after acute stroke. Circ J 71(7):1120–1127
Koton S, Howard SC, Warlow CP, Murphy MF, Rothwell PM (2008) Serum urate predicts long-term risk of acute coronary events in women after a transient ischaemic attack and stroke. Cerebrovasc Dis 26(5):517–524
Dawson J, Lees KR, Weir CJ, Quinn T, Ali M, Hennerici MG, Walters MR (2009) Baseline serum urate and 90-day functional outcomes following acute ischemic stroke. Cerebrovasc Dis 28(2):202–203
Kurzepa J, Bielewicz J, Stelmasiak Z, Bartosik-Psujek H (2009) Serum bilirubin and uric acid levels as the bad prognostic factors in the ischemic stroke. Int J Neurosci 119(12):2243–2249
Brouns R, Wauters A, Van De Vijver G, De Surgeloose D, Sheorajpanday R, De Deyn PP (2010) Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome. Clin Chem Lab Med 48(3):383–390
Seet RC, Kasiman K, Gruber J, Tang SY, Wong MC, Chang HM, Chan YH, Halliwell B, Chen CP (2010) Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study. Atherosclerosis 209(1):215–219
Zhang B, Gao C, Yang N, Zhang W, Song X, Yin J, Pu S, Yi Y, Gao Q (2010) Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke? BMC Neurol 1082
Amaro S, Urra X, Gomez-Choco M, Obach V, Cervera A, Vargas M, Torres F, Rios J, Planas AM, Chamorro A (2011) Uric acid levels are relevant in patients with stroke treated with thrombolysis. Stroke 42(1 Suppl):S28–S32
Chen H, Li F, Wang X, Kong Y, Wang Y (2011) Retrospective analysis of the predictive effect of routine biochemical results on the prognosis of intracerebral hemorrhage. Acta Neurochir Suppl 111403–406
Gao C, Zhang B, Zhang W, Pu S, Yin J, Gao Q (2011) Serum prealbumin (transthyretin) predict good outcome in young patients with cerebral infarction. Clin Exp Med 11(1):49–54
Logallo N, Naess H, Idicula TT, Brogger J, Waje-Andreassen U, Thomassen L (2011) Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study. BMC Neurol 11114
Xu J, Wang W, Shi H, Chen S, Liu Z, Li W, Zhang J, Li Y, Chen N (2011) Chronic kidney disease is prevalent in Chinese patients admitted with verified cerebrovascular lesions and predicts short-term prognosis. Nephrol Dial Transplant 26(8):2590–2594
Miedema I, Uyttenboogaart M, Koch M, Kremer B, de Keyser J, Luijckx GJ (2012) Lack of association between serum uric acid levels and outcome in acute ischemic stroke. J Neurol Sci 319(1–2):51–55
Zhang XL, Zhang JT, Peng Y, Xu Y, Zhang YH (2012) Association between serum uric acid and short-term clinical outcome among patients with acute stroke. Zhonghua Liu Xing Bing Xue Za Zhi 33(5):529–533
Chiquete E, Ruiz-Sandoval JL, Murillo-Bonilla LM, Arauz A, Orozco-Valera DR, Ochoa-Guzman A, Villarreal-Careaga J, Leon-Jimenez C, Barinagarrementeria F, Ramos-Moreno A, Cantu-Brito C (2013) Serum uric acid and outcome after acute ischemic stroke: PREMIER study. Cerebrovasc Dis 35(2):168–174
Lee SH, Heo SH, Kim JH, Lee D, Lee JS, Kim YS, Kim HY, Koh SH, Chang DI (2014) Effects of uric acid levels on outcome in severe ischemic stroke patients treated with intravenous recombinant tissue plasminogen activator. Eur Neurol 71(3–4):132–139
Wu D, Wang L, Teng W, Huang K, Shang X (2014) Correlation of fatigue during the acute stage of stroke with serum uric Acid and glucose levels, depression, and disability. Eur Neurol 72(3–4):223–227
Wu H, Jia Q, Liu G, Liu L, Pu Y, Zhao X, Wang C, Wang Y (2014) Decreased uric acid levels correlate with poor outcomes in acute ischemic stroke patients, but not in cerebral hemorrhage patients. J Stroke Cerebrovasc Dis 23(3):469–475
Yang N, Zhang B, Xie L, Yin J, He Y, Yang X, Gao C (2014) The association baseline NIH Stroke Scale score with ABO blood-subtypes in young patients with acute ischemic stroke. Atherosclerosis 236(1):144–149
Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, Ishimoto T, Sautin YY, Lanaspa MA (2013) Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 62(10):3307–3315
Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA (2009) Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum 61(7):885–892
Chamorro A, Amaro S, Castellanos M, Segura T, Arenillas J, Marti-Fabregas J, Gallego J, Krupinski J, Gomis M, Canovas D, Carne X, Deulofeu R, Roman LS, Oleaga L, Torres F, Planas AM (2014) Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial. Lancet Neurol 13(5):453–460
Dimitroula HV, Hatzitolios AI, Karvounis HI (2008) The role of uric acid in stroke: the issue remains unresolved. Neurologist 14(4):238–242
Amaro S, Canovas D, Castellanos M, Gallego J, Marti-Febregas J, Segura T, Chamorro A (2010) The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4.5 h of onset of symptoms. Int J Stroke 5(4):325–328
Compliance with Ethical Standards
There was no funding for the study. The present study was a meta-analysis, which did not involve human participants and/or animals. In addition, no informed consent was needed in the meta-analysis.
Conflicts of interest
None declared.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Zhongchao Wang, Yuxiu Liu and Ying Chen contributed equally to this work.
Rights and permissions
About this article
Cite this article
Wang, Z., Lin, Y., Liu, Y. et al. Serum Uric Acid Levels and Outcomes After Acute Ischemic Stroke. Mol Neurobiol 53, 1753–1759 (2016). https://doi.org/10.1007/s12035-015-9134-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-015-9134-1